Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Bayer AG

EMA Says Yes To BMS’ Sotyktu But Turns Down Ipsen’s Sohonos

The European Medicines Agency has recommended pan-EU marketing approval for four medicines but turned down Ipsen’s treatment for an ultra-rare bone disorder. It has also OK’d new uses of seven already-approved drugs and is reviewing efficacy concerns regarding Novartis’ sickle cell medicine.

Europe Approvals

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances

The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and experts reveal what they are most excited about on the technology front.

Scrip Asks Innovation

Astellas Plots US Portfolio Expansion

US president Mark Reisenauer talked to Scrip about the company's next growth drivers, including fezolinetant for vasomotor symptoms and zolbetuximab for gastric cancer.

Business Strategies Launches

10 Clinical Trials To Watch Out For In 2023

Scrip surveys the Phase III clinical trial readout landscape and picks 10 of the more interesting studies set to report in 2023, with a few added extras. AstraZeneca, Novo Nordisk, Novartis and Roche feature heavily.

Scrip Perspectives Clinical Trials
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
    • Radiopharmaceuticals, Contrast Agents
  • Digital Health
    • Artificial Intelligence
  • Other Names / Subsidiaries
    • Actus Therapeutics, Inc.
    • AskBio
    • Asklepios BioPharmaceutical, Inc.
    • Synpromics, Ltd.
    • RoverMed BioSciences
    • NanoCor Therapeutics
    • BrainVectis
    • Algeta ASA
    • Bayer CropScience AG
    • Bayer Consumer Care AG
    • Berlex Laboratories
    • BlueRock Therapeutics
    • Conceptus Inc.
    • Dihon Pharmaceutical Group Co., Ltd.
    • Intendis GmbH
    • Jenapharm
    • Medrad Inc.
    • Possis Medical
    • Schering AG
    • Monsanto Company
    • Zeptosens AG
    • KaNDy Therapeutics
    • Vividion Therapeutics, Inc.
UsernamePublicRestriction

Register